These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 1325087)
1. The pathobiology of salivary gland. II. Morphological evaluation of acinic cell carcinomas in the parotid gland of male transgenic (MMTV/v-Ha-ras) mice as a model for human tumours. Dardick I; Burford-Mason AP; Garlick DS; Carney WP Virchows Arch A Pathol Anat Histopathol; 1992; 421(2):105-13. PubMed ID: 1325087 [TBL] [Abstract][Full Text] [Related]
2. Harderian gland pathology in transgenic mice carrying the MMTV/v-Ha-ras gene. White V; Sinn E; Albert DM Invest Ophthalmol Vis Sci; 1990 Mar; 31(3):577-81. PubMed ID: 2156784 [TBL] [Abstract][Full Text] [Related]
4. Early and multifocal tumors in breast, salivary, harderian and epididymal tissues developed in MMTY-Neu transgenic mice. Lucchini F; Sacco MG; Hu N; Villa A; Brown J; Cesano L; Mangiarini L; Rindi G; Kindl S; Sessa F Cancer Lett; 1992 Jul; 64(3):203-9. PubMed ID: 1322235 [TBL] [Abstract][Full Text] [Related]
5. Histopathological features of the Harderian glands in transgenic mice carrying MMTV/N-ras protooncogene. Coto-Montes A; Rodríguez-Colunga MJ; Tolivia D; Sánchez-Barceló E Microsc Res Tech; 1997 Aug; 38(3):311-4. PubMed ID: 9264342 [TBL] [Abstract][Full Text] [Related]
6. Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo. Sinn E; Muller W; Pattengale P; Tepler I; Wallace R; Leder P Cell; 1987 May; 49(4):465-75. PubMed ID: 3032456 [TBL] [Abstract][Full Text] [Related]
7. A farnesyltransferase inhibitor induces tumor regression in transgenic mice harboring multiple oncogenic mutations by mediating alterations in both cell cycle control and apoptosis. Barrington RE; Subler MA; Rands E; Omer CA; Miller PJ; Hundley JE; Koester SK; Troyer DA; Bearss DJ; Conner MW; Gibbs JB; Hamilton K; Koblan KS; Mosser SD; O'Neill TJ; Schaber MD; Senderak ET; Windle JJ; Oliff A; Kohl NE Mol Cell Biol; 1998 Jan; 18(1):85-92. PubMed ID: 9418856 [TBL] [Abstract][Full Text] [Related]
9. Tumorigenesis and male sterility in transgenic mice expressing a MMTV/N-ras oncogene. Mangues R; Seidman I; Pellicer A; Gordon JW Oncogene; 1990 Oct; 5(10):1491-7. PubMed ID: 2174525 [TBL] [Abstract][Full Text] [Related]
10. Histopathology of salivary and mammary gland tumors in transgenic mice expressing a human Ha-ras oncogene. Nielsen LL; Discafani CM; Gurnani M; Tyler RD Cancer Res; 1991 Jul; 51(14):3762-7. PubMed ID: 2065330 [TBL] [Abstract][Full Text] [Related]
11. Ectopic vasopressin expression in MMTV-v-Ha-ras transgenic mice delays the onset of mammary tumorigenesis. Chooi KF; Carter DA; Murphy D Eur J Cancer; 1996 Jan; 32A(1):122-7. PubMed ID: 8695219 [TBL] [Abstract][Full Text] [Related]
12. Chemical effects in transgenic mice bearing oncogenes expressed in mammary tissue. Tennant RW; Rao GN; Russfield A; Seilkop S; Braun AG Carcinogenesis; 1993 Jan; 14(1):29-35. PubMed ID: 8093862 [TBL] [Abstract][Full Text] [Related]
13. Expression of an activated Notch-related int-3 transgene interferes with cell differentiation and induces neoplastic transformation in mammary and salivary glands. Jhappan C; Gallahan D; Stahle C; Chu E; Smith GH; Merlino G; Callahan R Genes Dev; 1992 Mar; 6(3):345-55. PubMed ID: 1372276 [TBL] [Abstract][Full Text] [Related]
14. Use of mouse mammary tumour virus (MMTV)/neu transgenic mice to identify genes collaborating with the c-erbB-2 oncogene in mammary tumour development. Jolicoeur P; Bouchard L; Guimond A; Ste-Marie M; Hanna Z; Dievart A Biochem Soc Symp; 1998; 63():159-65. PubMed ID: 9513720 [TBL] [Abstract][Full Text] [Related]
15. Loss of p21WAF1/CIP1 accelerates Ras oncogenesis in a transgenic/knockout mammary cancer model. Adnane J; Jackson RJ; Nicosia SV; Cantor AB; Pledger WJ; Sebti SM Oncogene; 2000 Nov; 19(47):5338-47. PubMed ID: 11103935 [TBL] [Abstract][Full Text] [Related]
16. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis. Amundadottir LT; Johnson MD; Merlino G; Smith GH; Dickson RB Cell Growth Differ; 1995 Jun; 6(6):737-48. PubMed ID: 7669729 [TBL] [Abstract][Full Text] [Related]
17. Parotid gland tumours in the ENT Department in Międzyleski Hospital in Warsaw between 2007 and 2014. Dżaman K; Pietniczka-Załęska M; Piskadło-Zborowska K; Siek M; Żebrowska J Otolaryngol Pol; 2016 Feb; 70(1):34-40. PubMed ID: 26926306 [TBL] [Abstract][Full Text] [Related]
18. NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice. Krane IM; Leder P Oncogene; 1996 Apr; 12(8):1781-8. PubMed ID: 8622899 [TBL] [Abstract][Full Text] [Related]
19. Synchronous bilateral epithelial-myoepithelial carcinoma of the parotid gland: case report and review of the literature. van Tongeren J; Creytens DH; Meulemans EV; de Bondt RB; de Jong J; Manni JJ Eur Arch Otorhinolaryngol; 2009 Sep; 266(9):1495-500. PubMed ID: 18841376 [TBL] [Abstract][Full Text] [Related]
20. [Sialadenosis of the parotid gland. Ultrastructural, clinical and experimental findings in disturbances of secretion (author's transl)]. Donath K Veroff Pathol; 1976; (103):1-122. PubMed ID: 1007613 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]